News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
524,511 Results
Type
Article (39071)
Company Profile (184)
Press Release (485256)
Section
Business (156941)
Career Advice (1760)
Deals (30001)
Drug Delivery (105)
Drug Development (73791)
Employer Resources (133)
FDA (12088)
Job Trends (11919)
News (280384)
Policy (30344)
Tag
Academia (2042)
Alliances (47463)
Alzheimer's disease (1113)
Approvals (12019)
Artificial intelligence (123)
Bankruptcy (279)
Best Places to Work (9125)
Biotechnology (95)
Breast cancer (95)
Cancer (933)
Cardiovascular disease (84)
Career advice (1455)
Cell therapy (191)
Clinical research (58769)
Collaboration (358)
Compensation (172)
COVID-19 (2527)
C-suite (80)
Data (947)
Diabetes (137)
Diagnostics (4131)
Drug pricing (97)
Earnings (56496)
Employer resources (121)
Events (71448)
Executive appointments (243)
FDA (12530)
Funding (275)
Gene therapy (165)
GLP-1 (647)
Government (4321)
Healthcare (13351)
Infectious disease (2615)
Inflammatory bowel disease (94)
Interviews (295)
IPO (12756)
Job creations (3130)
Job search strategy (1273)
Layoffs (366)
Legal (7958)
Lung cancer (154)
Manufacturing (177)
Medical device (6784)
Medtech (6788)
Mergers & acquisitions (17316)
Metabolic disorders (426)
Neuroscience (1368)
NextGen Class of 2024 (4647)
Non-profit (3122)
Northern California (1135)
Obesity (255)
Opinion (221)
Patents (94)
People (42808)
Pharmaceutical (80)
Phase I (18107)
Phase II (25589)
Phase III (19869)
Pipeline (414)
Policy (84)
Postmarket research (2298)
Preclinical (7375)
Radiopharmaceuticals (235)
Rare diseases (193)
Real estate (4429)
Regulatory (19310)
Research institute (1882)
Resumes & cover letters (272)
Southern California (972)
Startups (2831)
United States (9943)
Vaccines (604)
Weight loss (214)
Date
Today (100)
Last 7 days (614)
Last 30 days (3004)
Last 365 days (28489)
2024 (26074)
2023 (31670)
2022 (41272)
2021 (44206)
2020 (42358)
2019 (35485)
2018 (27109)
2017 (26540)
2016 (25425)
2015 (29239)
2014 (23132)
2013 (19355)
2012 (20643)
2011 (21281)
2010 (19582)
Location
Africa (730)
Arizona (101)
Asia (35133)
Australia (5523)
California (2481)
Canada (1046)
China (213)
Colorado (115)
Connecticut (107)
Europe (77656)
Florida (351)
Illinois (246)
Indiana (160)
Maryland (487)
Massachusetts (1933)
Michigan (85)
Minnesota (138)
New Jersey (798)
New York (764)
North Carolina (530)
Northern California (1135)
Ohio (104)
Pennsylvania (604)
South America (1041)
Southern California (972)
Texas (316)
Washington State (247)
524,511 Results for "noxxon pharma ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs)
September 25, 2024
·
1 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
Zealand Pharma A/S announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending granting marketing authorization for dasiglucagon solution for injection in the treatment of severe hypoglycemia in adults, adolescents, and children aged 6 years and over with diabetes mellitus.
May 31, 2024
·
5 min read
BioCapital
Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda
Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B, and age-related diseases, announced that the agreed equity investment by Takeda has been closed on June 20, 2024, with all proceeds already received.
June 20, 2024
·
3 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
1 of 52,452
Next